Eps Diluted - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epizyme Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
EPS (Diluted)
-$1
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$2
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-15%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$5
CAGR 3-Years
-17%
CAGR 5-Years
-15%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
-$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$37
CAGR 3-Years
-13%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Epizyme Inc's EPS (Diluted)?
EPS (Diluted)
-1.2 USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's EPS (Diluted) amounts to -1.2 USD.

What is Epizyme Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
10%

Over the last year, the EPS (Diluted) growth was 51%. The average annual EPS (Diluted) growth rates for Epizyme Inc have been 7% over the past three years , 10% over the past five years .

Back to Top